Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013513 |
---|---|
Receipt number | R000007653 |
Scientific Title | Phase 2 clinical trial of primary systemic therapy for primary breast cancer Sequential regimen of Nab-Paclitaxel followed by EC for HER2 negative breast cancer and concurrent regimen of Docetaxel/Carboplatin/Herceptin for HER2 positive breast cancer |
Date of disclosure of the study information | 2014/03/25 |
Last modified on | 2014/03/25 19:58:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/25 19:59:00 |